0001599298-19-000002.txt : 20190118 0001599298-19-000002.hdr.sgml : 20190118 20190118160140 ACCESSION NUMBER: 0001599298-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190118 DATE AS OF CHANGE: 20190118 EFFECTIVENESS DATE: 20190118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Therapeutics plc CENTRAL INDEX KEY: 0001599298 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-330956 FILM NUMBER: 19533289 BUSINESS ADDRESS: STREET 1: 136A EASTERN AVENUE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4SB BUSINESS PHONE: 44-123-544-3939 MAIL ADDRESS: STREET 1: 136A EASTERN AVENUE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4SB FORMER COMPANY: FORMER CONFORMED NAME: Summit Corp plc DATE OF NAME CHANGE: 20140205 D 1 primary_doc.xml X0708 D LIVE 0001599298 Summit Therapeutics plc 136A EASTERN AVENUE MILTON PARK ABINGDON X0 UNITED KINGDOM OX14 4SB 44-123-544-3939 UNITED KINGDOM Summit Corp plc Corporation true Glyn Edwards 136A Eastern Avenue Milton Park Abingdon X0 UNITED KINGDOM OX14 4SB Executive Officer Director David Roblin 136A Eastern Avenue Milton Park Abingdon X0 UNITED KINGDOM OX14 4SB Executive Officer Frank Armstrong 136A Eastern Avenue Milton Park Abingdon X0 UNITED KINGDOM OX14 4SB Director Leopoldo Zambeletti 136A Eastern Avenue Milton Park Abingdon X0 UNITED KINGDOM OX14 4SB Director Valerie Andrews 136A Eastern Avenue Milton Park Abingdon X0 UNITED KINGDOM OX14 4SB Director David Wurzer 136A Eastern Avenue Milton Park Abingdon X0 UNITED KINGDOM OX14 4SB Director Biotechnology Decline to Disclose 06b false 2019-01-09 false true false 0 25000000 25000000 0 false 1 0 0 0 false Summit Therapeutics plc /s/ Glyn Edwards Glyn Edwards Chief Executive Officer 2019-01-18